Navigation Links
Extra hormone found to cut appetite by a third

Studies done previously have shown that the hormone could suppress the appetites of lean people. But researchers were worried it would not work in obese people because studies of another appetite-suppressing hormone,// leptin, had proved disappointing.

"We had to do a second trial to see if obese people were as sensitive" to the hormone, said researchers. The answer: "Yes, they are. They're just as sensitive as thin people."

In a small study done , both obese and lean people ate about 30 percent less from a buffet lunch after they were given a dose of the hormone, PYY3-36, to trick the brain into thinking they had already eaten. The research also showed lower natural levels of PYY in the obese, which may explain why they are hungrier and overeat.

However researchers say long-term use of the hormone would have to be studied before it could be developed into a treatment for obesity that would consist of injections given before meals. "We haven't yet shown you get actual weight reduction. We've only shown you eat less," researchers said.

The findings could also point to a more natural treatment for obesity: A high-fiber diet is believed to boost the body's production of PYY.

The PYY hormone, one of a number of hormones that stimulate or suppress hunger, is released by the gut as you eat. It tells the part of the brain that controls appetite when you are full. Dr. Rudolph L. Leibel, an obesity researcher , said it is unlikely that PYY alone will turn out to be the "magic bullet" against obesity, but it may prove useful in combination with other drugs. He said the body has backup systems that kick in to resist the loss of body fat -- the reason so many people who lose weight gain it back.

"We can't fool Mother Nature yet," he said. Currently, there are only a few prescription weight-control drugs, and they produce only modest weight loss. They work by suppressing the appetite through a brain chemical or by blockin g fat from being absorbed.

The British researchers recruited 24 people: 12 obese and 12 lean. Their food consumption was monitored twice, once after an intravenous dose of synthetic PYY and once after getting a harmless saline solution. Two hours later, they were given a large buffet lunch.

After the PYY dose, the obese ate 30 percent fewer calories than they did after the dummy solution. The lean people ate 31 percent less. The PYY continued to curb their appetites for 12 hours, with the obese eating 26 percent less and the lean eating about 34 percent less, based on food diaries they kept.

The PYY did not affect food consumption from 12 hours to 24 hours after the infusion. Without the extra dose, PYY levels were lower in the obese participants than in the lean, but the researchers said it is not known whether that is a cause of obesity or a consequence.

If it's a consequence of obesity, it would explain why once people become overweight, it is very difficult for them to reverse it. They don't feel as feel as full after food as normal people do as a result of their obesity.
'"/>




Related medicine news :

1. Is Drinking Extra Fluids Safe When You’re Sick
2. Extracts of grapefruit heals stomach ulcers
3. Yet Another Use For Green Tea Extract
4. Tomato Extract Found To Reduce The Risk Of Thrombosis
5. Slowing Cartilage Loss In Arthritis With Fruit Extracts
6. Extravagant Pay For Emergency Department Head Of Caboolture Hospital
7. High Blood Pressure Can Be Treated With Grape Seed Extract
8. Saw Palmetto Extract No Good In Improving Prostate Health
9. Greenpeace Says 93,000 Extra Cancer Deaths Due To Chernobyl Fallout
10. NHS To Take Extra Care Of The Aged
11. Western Australian Government Spending Extra For Mental Health Services
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... As health ... medicine known as “patient engagement.” The patient is doing more than filling out a ... , “There is an increasing emphasis in health care and research on the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... ... 2017 , ... Lori R. Somekh, founder of the Law Office of ... elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain ... to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
Breaking Medicine Technology: